Annual gross profit:
$483.50M+$94.46M(+24.28%)Summary
- As of today (July 7, 2025), RARE annual gross profit is $483.50 million, with the most recent change of +$94.46 million (+24.28%) on December 31, 2024.
- During the last 3 years, RARE annual gross profit has risen by +$148.10 million (+44.16%).
- RARE annual gross profit is now at all-time high.
Performance
RARE Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$110.63M-$37.35M(-25.24%)Summary
- As of today (July 7, 2025), RARE quarterly gross profit is $110.63 million, with the most recent change of -$37.35 million (-25.24%) on March 31, 2025.
- Over the past year, RARE quarterly gross profit has increased by +$19.33 million (+21.17%).
- RARE quarterly gross profit is now -25.24% below its all-time high of $147.98 million, reached on December 31, 2024.
Performance
RARE quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$502.83M+$19.33M(+4.00%)Summary
- As of today (July 7, 2025), RARE TTM gross profit is $502.83 million, with the most recent change of +$19.33 million (+4.00%) on March 31, 2025.
- Over the past year, RARE TTM gross profit has increased by +$110.73 million (+28.24%).
- RARE TTM gross profit is now at all-time high.
Performance
RARE TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
RARE Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.3% | +21.2% | +28.2% |
| 3 y3 years | +44.2% | +49.8% | +59.6% |
| 5 y5 years | +410.5% | +177.9% | +228.0% |
RARE Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.3% | -25.2% | +36.5% | at high | +61.0% |
| 5 y | 5-year | at high | +410.5% | -25.2% | +84.7% | at high | +228.0% |
| alltime | all time | at high | >+9999.0% | -25.2% | >+9999.0% | at high | >+9999.0% |
RARE Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $110.63M(-25.2%) | $502.83M(+4.0%) |
| Dec 2024 | $483.50M(+24.3%) | $147.98M(+24.9%) | $483.50M(+7.2%) |
| Sep 2024 | - | $118.47M(-5.8%) | $450.86M(+7.5%) |
| Jun 2024 | - | $125.75M(+37.7%) | $419.45M(+7.0%) |
| Mar 2024 | - | $91.30M(-20.8%) | $392.10M(+0.8%) |
| Dec 2023 | $389.04M(+16.1%) | $115.34M(+32.5%) | $389.04M(+4.7%) |
| Sep 2023 | - | $87.06M(-11.5%) | $371.73M(+1.4%) |
| Jun 2023 | - | $98.39M(+11.5%) | $366.74M(+5.0%) |
| Mar 2023 | - | $88.24M(-10.0%) | $349.41M(+4.3%) |
| Dec 2022 | $335.01M(-0.1%) | $98.03M(+19.4%) | $335.01M(+5.7%) |
| Sep 2022 | - | $82.07M(+1.2%) | $316.86M(+1.5%) |
| Jun 2022 | - | $81.07M(+9.8%) | $312.26M(-0.9%) |
| Mar 2022 | - | $73.83M(-7.6%) | $315.03M(-6.1%) |
| Dec 2021 | $335.40M(+26.6%) | $79.88M(+3.1%) | $335.40M(-1.8%) |
| Sep 2021 | - | $77.47M(-7.6%) | $341.58M(-0.5%) |
| Jun 2021 | - | $83.84M(-11.0%) | $343.23M(+7.5%) |
| Mar 2021 | - | $94.21M(+9.5%) | $319.30M(+20.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $264.90M(+179.7%) | $86.06M(+8.8%) | $264.90M(+26.5%) |
| Sep 2020 | - | $79.12M(+32.1%) | $209.33M(+36.5%) |
| Jun 2020 | - | $59.91M(+50.5%) | $153.32M(+31.3%) |
| Mar 2020 | - | $39.81M(+30.6%) | $116.80M(+23.3%) |
| Dec 2019 | $94.71M(+88.1%) | $30.49M(+31.9%) | $94.71M(+18.4%) |
| Sep 2019 | - | $23.12M(-1.1%) | $79.97M(+17.0%) |
| Jun 2019 | - | $23.38M(+32.0%) | $68.35M(+18.6%) |
| Mar 2019 | - | $17.72M(+12.5%) | $57.62M(+14.4%) |
| Dec 2018 | $50.35M(+1828.3%) | $15.75M(+37.1%) | $50.35M(+36.0%) |
| Sep 2018 | - | $11.49M(-9.2%) | $37.01M(+43.9%) |
| Jun 2018 | - | $12.65M(+21.1%) | $25.72M(+96.9%) |
| Mar 2018 | - | $10.45M(+333.2%) | $13.06M(+400.3%) |
| Dec 2017 | $2.61M(+1863.2%) | $2.41M(+1118.7%) | $2.61M(+1218.7%) |
| Sep 2017 | - | $198.00K(>+9900.0%) | $198.00K(>+9900.0%) |
| Mar 2017 | - | $0.00 | $0.00 |
| Dec 2016 | $133.00K(>+9900.0%) | - | - |
| Dec 2015 | $0.00 | - | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual gross profit?
- What is the all time high annual gross profit for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual gross profit year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly gross profit?
- What is the all time high quarterly gross profit for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly gross profit year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. TTM gross profit?
- What is the all time high TTM gross profit for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. TTM gross profit year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual gross profit?
The current annual gross profit of RARE is $483.50M
What is the all time high annual gross profit for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual gross profit is $483.50M
What is Ultragenyx Pharmaceutical Inc. annual gross profit year-on-year change?
Over the past year, RARE annual gross profit has changed by +$94.46M (+24.28%)
What is Ultragenyx Pharmaceutical Inc. quarterly gross profit?
The current quarterly gross profit of RARE is $110.63M
What is the all time high quarterly gross profit for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly gross profit is $147.98M
What is Ultragenyx Pharmaceutical Inc. quarterly gross profit year-on-year change?
Over the past year, RARE quarterly gross profit has changed by +$19.33M (+21.17%)
What is Ultragenyx Pharmaceutical Inc. TTM gross profit?
The current TTM gross profit of RARE is $502.83M
What is the all time high TTM gross profit for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high TTM gross profit is $502.83M
What is Ultragenyx Pharmaceutical Inc. TTM gross profit year-on-year change?
Over the past year, RARE TTM gross profit has changed by +$110.73M (+28.24%)